Kategorier: phase 2b

14 November 2022 13:34

Scandinavian Biopharma has successfully completed the enrolment of their large Phase 2b trial in The Gambia

All participants have received the third and final vaccination dose in our large randomized, placebo-controlled, and double-blind phase 2b study in The Gambia. The study includes 4 936 children aged 6-18 months. The overall goal of the study is to investigate the efficacy against moderate to severe diarrhea caused by ETEC.

26 Maj 2020 09:59

Promising preliminary findings from a Phase 2b study of the oral vaccine ETVAX® against travelers’ diarrhea in Finnish travelers to Benin, West Africa

Encouraging results from a Phase 2b study. The trial enrolled adult volunteers from Finland who travelled to Benin after receiving ETVAX® or placebo. The study results confirm the excellent safety and overall positive immunogenicity of ETVAX®, as well as a significant protective efficacy of 56% against all severe diarrhea, independent of pathogen.